WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003002746) PERV SCREENING METHOD AND USE THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2003/002746 International Application No.: PCT/EP2002/007159
Publication Date: 09.01.2003 International Filing Date: 28.06.2002
Chapter 2 Demand Filed: 17.01.2003
IPC:
A01K 67/027 (2006.01) ,C07K 14/15 (2006.01) ,C12N 15/85 (2006.01)
Applicants: HERRING, Christopher, Taylor[GB/GB]; GB (UsOnly)
LANGFORD, Gillian[GB/GB]; GB (UsOnly)
QUINN, Gary[IE/US]; US (UsOnly)
SCOBIE, Linda[GB/GB]; GB (UsOnly)
NOVARTIS AG[CH/CH]; Lichtstrasse 35 CH-4056 Basel, CH (AE, AG, AL, AM, AU, AZ, BA, BB, BE, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, FR, GB, GD, GE, GH, GR, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LT, LU, LV, MA, MC, MD, MK, MN, MX, NL, NO, NZ, OM, PH, PL, PT, RO, RU, SE, SG, SI, SK, TJ, TM, TN, TR, TT, UA, UZ, VN, YU, ZA, ZW)
NOVARTIS PHARMA GMBH[AT/AT]; Brunner Strasse 59 A-1230 Vienna, AT (AT)
Inventors: HERRING, Christopher, Taylor; GB
LANGFORD, Gillian; GB
QUINN, Gary; US
SCOBIE, Linda; GB
Agent: GROS, Florent; Novartis AG Corporate Intellectual Property Patent & Trademark Department CH-4002 Basel, CH
Priority Data:
60/302,13329.06.2001US
Title (EN) PERV SCREENING METHOD AND USE THEREOF
(FR) METHODE DE CRIBLAGE DE PERV ET SON UTILISATION
Abstract:
(EN) The invention relates to porcine endogenous retrovirus (PERV) and novel methods of identification, isolation and screening via polynucleotides sequences. It also relates to use of said methods in providing a pig that does not express porcine endogenous retrovirus. The organs, tissues and cells of said pig being capable of use for xenotransplantation.
(FR) L'invention concerne le rétrovirus porcin endogène (PERV) et de nouvelles méthodes d'identification, d'isolation et de criblage via des séquences polynucléotidiques. L'invention concerne également l'utilisation de ces méthodes afin d'obtenir un porc qui n'exprime pas le rétrovirus porcin endogène. Les organes, les tissus et les cellules de ce porc peuvent être utilisés à des fins de xénotransplantation.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LT, LU, LV, MA, MD, MK, MN, MX, NO, NZ, OM, PH, PL, PT, RO, RU, SE, SG, SI, SK, TJ, TM, TN, TR, TT, UA, US, UZ, VN, YU, ZA, ZW
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
Publication Language: English (EN)
Filing Language: English (EN)